Search

Search Constraints

You searched for: Author/Creator Motomura, Shigeki

Search Results

1. Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy. Issue 2 (February 2015)

2. Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy. Issue 11 (November 2015)

3. Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum. Issue 5 (May 2013)

4. Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Issue 9 (2nd September 2015)

5. Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study. Issue 12 (December 2014)

6. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. Issue 3 (March 2015)

7. MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy. Issue 12 (27th November 2013)

8. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B‐cell lymphoma in the rituximab era. (28th November 2013)

9. Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms. (2nd January 2014)

10. Prognostic significance of programmed cell death‐1‐positive cells in follicular lymphoma patients may alter in the rituximab era. (7th March 2013)